Table 1.
Baseline characteristics of T1 and T2 at inclusion and p value for differences between the cohorts, differences between women in T1 and T2 and differences between men in T1 and T2
| Total | Women | Men | |||||||
|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | p | T1 | T2 | p | T1 | T2 | p | |
| n = 276 | n = 340 | n = 187 | n = 239 | n = 89 | n = 101 | ||||
| Age (yrs) | 56 (15) | 59 (14) | 0.019 | 54 (15) | 58 (13) | 0.013 | 60 (13) | 62 (14) | 0.481 |
| Cohabiting (%) | 73 | 73 | 0.978 | 70 | 71 | 0.961 | 78 | 78 | 0.979 |
| Education (yrs) | 10.6 (2.1) | 11.0 (2.3) | 0.025 | 10.7(2.1) | 11.2 (2.3) | 0.050 | 10.3(2.0) | 10.6(2.1) | 0.351 |
| DAS28 | 5.3 (1.2) | 5.1 (1.3) | 0.102 | 5.3 (1.2) | 5.2 (1.2) | 0.305 | 5.3 (1.0) | 5.0 (1.4) | 0.154 |
| HAQ (0–3) | 0.9 (0.6) | 1.0 (0.6) | 0.094 | 0.9 (0.6) | 1.0 (0.6) | 0.090 | 0.8 (0.5) | 0.8 (0.6) | 0.715 |
| Pain (VAS) | 48 (25) | 53 (25) | 0.017 | 48 (24) | 54 (24) | 0.030 | 47 (26) | 51 (26) | 0.310 |
| EQ5D (0–1) | 0.59 (0.26) | 0.55 (0.27) | 0.107 | 0.60(0.25) | 0.55(0.27) | 0.044 | 0.57(0.27) | 0.57(0.28) | 0.966 |
| EQ-VAS (0–100) | 58 (19) | 57 (21) | 0.478 | 59 (20) | 56 (21) | 0.176 | 58 (19) | 60 (20) | 0.397 |
DAS28 28 joint disease activity score, HAQ Health Assessment Questionnaire, VAS visual analogue scale, EQ-5D EuroQol 5-Dimensions, EQ-VAS general health, visual analogue scale